Purchase Order 36C24120P0806
- Not listed
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $76,993.80 contract is for the provision of Infinium Methylation EPIC supplies and accessories, with no set-aside designation. Illumina has previously held prime federal contracts and subcontracts with agencies such as the NIH, CDC, USDA, and VA to provide a range of genomic sequencing...
- The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $274,063.35, is for the provision of proprietary DNA testing kits, including the Multi-Ethnic Global, EPIC, and PsychArray Kits, to support the VA's genetic analysis and research requirements. The contract does not have a set-aside designation. Illumina has previously provided sequencing...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, for the provision of Genetic Beadchip Kits. The contract, valued at $398,806.06, does not have a set-aside designation and is set to expire on September 30, 2017. Illumina has a history of providing sequencing instruments, reagents, and support services to various federal agencies,...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the delivery of DNA BeadChip Kits. The $157,656.93 firm fixed price contract was awarded without any set-aside provisions. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery to provide sequencing platforms,...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $157,400.64 contract is for the delivery of multi-ethnic genotyping kits, with a completion date of May 8, 2018. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA for genomic...
- This is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $115,817.23, is for the provision of INFINIUM METHYLATION EPIC SAMPLES, which are likely related to genomic sequencing and analysis services. The contract has no set-aside designation and is not associated with a larger indefinite delivery...
- The Department of Veterans Affairs (VA) awarded a $272,276.80 firm fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of microarray kits, with a performance period ending on February 6, 2020. Illumina has a history of providing sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies, including the NIH, CDC,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...
- This is a $198,410.27 firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for DNA beadchip kits. The contract has an ultimate completion date of September 30, 2016 and does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal awards from agencies like the National Institutes of Health, Centers for Disease Control and Prevention,...
- This firm fixed-price contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of genomic sequencing and array-based solutions. The contract is for the provision of DNA BeadChip Kits, with a potential value of $105,899.20. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to supply a range of genomic sequencing instruments, reagents, and bioinformatics products in support of...
The Department of Veterans Affairs Veterans Health Administration awarded a $150,176.00 firm fixed price purchase order contract to Illumina, Inc. to provide Infinium MethylationEPIC and Multi-Ethnic Global genotyping and epigenetic analysis kits based on bead array technology. These kits enable highly multiplexed measurement of DNA methylation at individual CpG loci across the human genome. The contract has no set-aside designation. Through past prime federal awards, Illumina has supplied a range of sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics for agencies like the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Agriculture. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide reagents and controls for its sequencing platforms used in biological threat characterization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $150.2k | 7/7/20 |